Skip to content

Abivax

  • EN
  • FR
  • About Abivax
    • Our Mission
    • Company History
    • Our Leadership
    • Contact Us
  • Our Science
    • Novel MOA
    • Obefazimod
  • Our Research
  • Our Pipeline
  • Publications
  • Investors
    • Overview
    • Press Releases
    • News
    • Share Price
    • Investor Documents
    • General Meeting
    • Corporate Presentation
  • EN
  • FR

News & Events

Press Coverage

  • 2023
  • 2022
  • 2021
  • 2020
  • 2019

MedNous

May 18, 2020

Abivax to receive €36 million for COVID-19 programme

actu.fr

May 16, 2020

Coronavirus. Abivax recrute 1 034 patients atteints du Covid-19 pour un essai clinique

Biotech Finances

May 15, 2020

Abivax entre dans la course contre COVID-19 avec un financement non dilutif de 36 M€

RTL

May 15, 2020

Coronavirus : qu’est-ce que le ABX464, nouveau médicament d’Abivax en test ?

Charente Libre

May 15, 2020

Nouvel essai contre le Covid

  • 1
  • …
  • 26
  • 27
  • 28
  • 29
  • 30
  • …
  • 46

References available upon request.

© 2025 All rights reserved by Abivax 07/2024 Privacy and Terms of Use
Consent Preferences
  • About Abivax
    • Our Mission
    • Company History
    • Our Leadership
    • Contact Us
  • Our Science
    • Novel MOA
    • Obefazimod
  • Our Research
  • Our Pipeline
  • Publications
  • Investors
    • Overview
    • Press Releases
    • News
    • Share Price
    • Investor Documents
    • General Meeting
    • Corporate Presentation
Contact Us
  • Follow us on Twitter
  • Follow us on LinkedIn